These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 35830029)
21. Differentiation of tuberculous peritonitis from peritonitis carcinomatosa without surgical intervention. Kaya M; Kaplan MA; Isikdogan A; Celik Y Saudi J Gastroenterol; 2011; 17(5):312-7. PubMed ID: 21912057 [TBL] [Abstract][Full Text] [Related]
22. [Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure]. Roldan-Molina F; de Oliveira e Silva A; dos Santos TE; Genzini T; de Miranda MP; de Oliveira RM; Santo GC; D'Albuquerque LA Arq Gastroenterol; 1992; 29(2):56-61. PubMed ID: 1284885 [TBL] [Abstract][Full Text] [Related]
23. Ascitic fluid analysis for the differentiation of malignancy-related and nonmalignant ascites. Proposal of a diagnostic sequence. Gerbes AL; Jüngst D; Xie YN; Permanetter W; Paumgartner G Cancer; 1991 Oct; 68(8):1808-14. PubMed ID: 1913524 [TBL] [Abstract][Full Text] [Related]
24. The role of ascitic fluid viscosity in the differential diagnosis of ascites. Gokturk HS; Demir M; Ozturk NA; Unler GK; Kulaksizoglu S; Kozanoglu I; Serin E; Yilmaz U Can J Gastroenterol; 2010 Apr; 24(4):255-9. PubMed ID: 20431815 [TBL] [Abstract][Full Text] [Related]
25. Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation. Wu SS; Lin OS; Chen YY; Hwang KL; Soon MS; Keeffe EB J Hepatol; 2001 Feb; 34(2):215-21. PubMed ID: 11281549 [TBL] [Abstract][Full Text] [Related]
26. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites. Rana SV; Babu SG; Kocchar R Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567 [TBL] [Abstract][Full Text] [Related]
27. Malignancy-related ascites: a diagnostic pitfall of spontaneous bacterial peritonitis by ascitic fluid polymorphonuclear cell count. Wang SS; Lu CW; Chao Y; Lee MY; Lin HC; Lee SD; Tsai YT; Chen CC; Lo KJ J Hepatol; 1994 Jan; 20(1):79-84. PubMed ID: 8201226 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites. Liu F; Kong X; Dou Q; Ye J; Xu D; Shang H; Xu K; Song Y Ann Hepatol; 2014; 13(3):357-63. PubMed ID: 24756011 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic algorithm based on ratio of ascites-serum tumor markers is superior to tumor markers in the differentiation of benign ascites from malignant ascites. Liu M; Zhang N; Wei X; Xiao Z; Song Y; Du L Am J Med Sci; 2024 Oct; 368(4):361-368. PubMed ID: 38880300 [TBL] [Abstract][Full Text] [Related]
30. CEA, AFP and CA 19-9 analysis in peritoneal fluid to differentiate causes of ascites formation. Kaleta EJ; Tolan NV; Ness KA; O'Kane D; Algeciras-Schimnich A Clin Biochem; 2013 Jun; 46(9):814-8. PubMed ID: 23454392 [TBL] [Abstract][Full Text] [Related]
31. [Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance]. Barbare JC; Diab G; Delavenne J; Philippe JM; Vorhauer W; Latrive JP; Capron JP Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):251-6. PubMed ID: 2619252 [TBL] [Abstract][Full Text] [Related]
32. [Ascitic fluid: the value of various biological tests in the differential diagnosis between cirrhotic and neoplastic ascites]. Ghilain JM; Henrion J; Schapira M; Majois F; Beauduin M; Heller FR Acta Gastroenterol Belg; 1990; 53(2):168-79. PubMed ID: 2267897 [TBL] [Abstract][Full Text] [Related]
33. High ascitic fluid leptin levels in patients with decompensated liver cirrhosis and sterile ascites: relationship with TNF-alpha levels. Giannini E; Romagnoli P; Tenconi GL; Botta F; Malfatti F; Chiarbonello B; Mamone M; Barreca T; Testa R Dig Dis Sci; 2004 Feb; 49(2):275-80. PubMed ID: 15104370 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of CEA and CA 19-9 tumor markers combined with cytology from peritoneal fluid in colorectal cancer. Lee IK; Kim DH; Gorden DL; Lee YS; Sung NY; Park GS; Kim HJ; Kang WK; Park JK; Ahn CH; Kim JG; Jeon HM; Oh ST Ann Surg Oncol; 2009 Apr; 16(4):861-70. PubMed ID: 19189191 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic paracentesis. A two-step approach. Sartori M; Andorno S; Gambaro M; Leone F; Molinari GL; Pontiroli L; Aglietta M Ital J Gastroenterol; 1996; 28(2):81-5. PubMed ID: 8781999 [TBL] [Abstract][Full Text] [Related]
37. Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites. Jüngst D; Gerbes AL; Martin R; Paumgartner G Hepatology; 1986; 6(2):239-43. PubMed ID: 3957233 [TBL] [Abstract][Full Text] [Related]
38. Diagnosing ascites: value of ascitic fluid total protein, albumin, cholesterol, their ratios, serum-ascites albumin and cholesterol gradient. Gupta R; Misra SP; Dwivedi M; Misra V; Kumar S; Gupta SC J Gastroenterol Hepatol; 1995; 10(3):295-9. PubMed ID: 7548806 [TBL] [Abstract][Full Text] [Related]
39. Patients with spontaneous bacterial peritonitis, and malignant and cirrhotic ascites. Yildirim B; Sari R; Isci N J Natl Med Assoc; 2005 Feb; 97(2):276-80. PubMed ID: 15712792 [TBL] [Abstract][Full Text] [Related]
40. Ascitic fluid analysis in hepatocellular carcinoma. Colli A; Cocciolo M; Riva C; Marcassoli L; Pirola M; Di Gregorio P; Buccino G Cancer; 1993 Aug; 72(3):677-82. PubMed ID: 8392901 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]